SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4i8v'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EA1_A_TPFA470_1
(CYTOCHROME P450
51-LIKE RV0764C)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 8 PHE A 480
PHE A 184
THR A 173
LEU A 170
 None
 1.05A 1ea1A-4i8vA:
29.6		 1ea1A-4i8vA:
23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T9W_A_NFNA6001_1
(ACRIFLAVINE
RESISTANCE PROTEIN B)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		3 / 3 SER A 127
GLY A 128
ARG A 392
 None
 0.64A 1t9wA-4i8vA:
2.6		 1t9wA-4i8vA:
18.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XDK_F_9CRF1600_2
(RETINOIC ACID
RECEPTOR, BETA)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		3 / 3 LEU A 177
PHE A 184
ARG A 477
 None
 0.76A 1xdkF-4i8vA:
undetectable		 1xdkF-4i8vA:
20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2B82_A_ADNA1001_1
(CLASS B ACID
PHOSPHATASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 10 PHE A 123
LEU A 496
GLY A 316
ASP A 320
THR A 111
 None
None
BHF  A 602 (-3.5A)
BHF  A 602 (-3.7A)
None
 1.43A 2b82A-4i8vA:
undetectable		 2b82A-4i8vA:
18.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NXE_A_SAMA302_1
(RIBOSOMAL PROTEIN
L11
METHYLTRANSFERASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		3 / 3 THR A 155
ASP A 361
SER A 363
 None
 0.56A 2nxeA-4i8vA:
undetectable		 2nxeA-4i8vA:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NXE_B_SAMB303_1
(RIBOSOMAL PROTEIN
L11
METHYLTRANSFERASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		3 / 3 THR A 155
ASP A 361
SER A 363
 None
 0.58A 2nxeB-4i8vA:
undetectable		 2nxeB-4i8vA:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W98_B_P1ZB1357_1
(PROSTAGLANDIN
REDUCTASE 2)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 6 TYR A 189
LEU A 215
ASN A 219
ASP A 320
 None
None
None
BHF  A 602 (-3.7A)
 1.26A 2w98A-4i8vA:
undetectable
2w98B-4i8vA:
undetectable		 2w98A-4i8vA:
21.38
2w98B-4i8vA:
21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZBU_D_ADND504_1
(UNCHARACTERIZED
CONSERVED PROTEIN)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		3 / 3 PHE A 224
ASN A 222
PHE A 319
 BHF  A 602 (-3.3A)
BHF  A 602 ( 3.8A)
BHF  A 602 ( 4.7A)
 0.94A 2zbuD-4i8vA:
undetectable		 2zbuD-4i8vA:
19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_2
(ADENOSYLHOMOCYSTEINA
SE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 4 LEU A  86
GLN A  94
THR A  91
THR A 390
 None
 1.47A 2zj0D-4i8vA:
undetectable		 2zj0D-4i8vA:
22.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZS9_A_PAUA603_0
(PANTOTHENATE KINASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 6 VAL A 311
ASP A 283
HIS A 269
TYR A 270
 None
 1.31A 2zs9A-4i8vA:
undetectable		 2zs9A-4i8vA:
21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3APX_A_Z80A190_1
(ALPHA-1-ACID
GLYCOPROTEIN 2)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 VAL A 218
THR A 323
PHE A 470
LEU A 159
ALA A 200
 None
 1.44A 3apxA-4i8vA:
undetectable		 3apxA-4i8vA:
16.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3E4E_A_4PZA501_1
(CYTOCHROME P450 2E1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		3 / 3 ALA A 317
THR A 321
CYH A 457
 BHF  A 602 ( 3.4A)
HEM  A 601 (-3.4A)
HEM  A 601 (-2.1A)
 0.40A 3e4eA-4i8vA:
44.9		 3e4eA-4i8vA:
35.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3E4E_B_4PZB501_1
(CYTOCHROME P450 2E1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		3 / 3 ALA A 317
THR A 321
CYH A 457
 BHF  A 602 ( 3.4A)
HEM  A 601 (-3.4A)
HEM  A 601 (-2.1A)
 0.34A 3e4eB-4i8vA:
44.8		 3e4eB-4i8vA:
35.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_A_SAMA300_0
(PUTATIVE RRNA
METHYLASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 THR A  54
GLY A  56
ASN A  58
ILE A  49
GLY A  50
 None
NO3  A 604 ( 4.2A)
NO3  A 604 (-4.3A)
None
None
 1.08A 3eeyA-4i8vA:
undetectable		 3eeyA-4i8vA:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_B_SAMB300_0
(PUTATIVE RRNA
METHYLASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 THR A  54
GLY A  56
ASN A  58
ILE A  49
GLY A  50
 None
NO3  A 604 ( 4.2A)
NO3  A 604 (-4.3A)
None
None
 1.09A 3eeyB-4i8vA:
undetectable		 3eeyB-4i8vA:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_F_SAMF300_0
(PUTATIVE RRNA
METHYLASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 THR A  54
GLY A  56
ASN A  58
ILE A  49
GLY A  50
 None
NO3  A 604 ( 4.2A)
NO3  A 604 (-4.3A)
None
None
 1.08A 3eeyF-4i8vA:
undetectable		 3eeyF-4i8vA:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_H_SAMH300_0
(PUTATIVE RRNA
METHYLASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 THR A  54
GLY A  56
ASN A  58
ILE A  49
GLY A  50
 None
NO3  A 604 ( 4.2A)
NO3  A 604 (-4.3A)
None
None
 1.09A 3eeyH-4i8vA:
undetectable		 3eeyH-4i8vA:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_I_SAMI300_0
(PUTATIVE RRNA
METHYLASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 THR A  54
GLY A  56
ASN A  58
ILE A  49
GLY A  50
 None
NO3  A 604 ( 4.2A)
NO3  A 604 (-4.3A)
None
None
 1.08A 3eeyI-4i8vA:
undetectable		 3eeyI-4i8vA:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HS4_A_AZMA702_1
(CARBONIC ANHYDRASE 2)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 7 LYS A 342
TYR A 367
GLU A 374
PRO A 429
 None
 1.25A 3hs4A-4i8vA:
undetectable		 3hs4A-4i8vA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OLS_B_ESTB600_1
(ESTROGEN RECEPTOR
BETA)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 LEU A 433
LEU A 428
ARG A 338
ILE A 439
LEU A 443
 None
 1.24A 3olsB-4i8vA:
undetectable		 3olsB-4i8vA:
19.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RUK_A_AERA601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 ASP A 313
ALA A 317
THR A 321
VAL A 382
CYH A 457
 BHF  A 602 (-3.7A)
BHF  A 602 ( 3.4A)
HEM  A 601 (-3.4A)
HEM  A 601 (-4.9A)
HEM  A 601 (-2.1A)
 0.77A 3rukA-4i8vA:
42.5		 3rukA-4i8vA:
33.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RUK_A_AERA601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 PHE A 123
ASP A 313
ALA A 317
THR A 321
CYH A 457
 None
BHF  A 602 (-3.7A)
BHF  A 602 ( 3.4A)
HEM  A 601 (-3.4A)
HEM  A 601 (-2.1A)
 0.63A 3rukA-4i8vA:
42.5		 3rukA-4i8vA:
33.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RUK_B_AERB601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 PHE A 123
ASP A 313
GLY A 316
ALA A 317
THR A 321
 None
BHF  A 602 (-3.7A)
BHF  A 602 (-3.5A)
BHF  A 602 ( 3.4A)
HEM  A 601 (-3.4A)
 0.60A 3rukB-4i8vA:
42.6		 3rukB-4i8vA:
33.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RUK_D_AERD601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 11 ASP A 313
GLY A 316
ALA A 317
THR A 321
VAL A 382
 BHF  A 602 (-3.7A)
BHF  A 602 (-3.5A)
BHF  A 602 ( 3.4A)
HEM  A 601 (-3.4A)
HEM  A 601 (-4.9A)
 0.73A 3rukD-4i8vA:
42.1		 3rukD-4i8vA:
33.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RUK_D_AERD601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 11 PHE A 123
ASP A 313
GLY A 316
ALA A 317
THR A 321
 None
BHF  A 602 (-3.7A)
BHF  A 602 (-3.5A)
BHF  A 602 ( 3.4A)
HEM  A 601 (-3.4A)
 0.66A 3rukD-4i8vA:
42.1		 3rukD-4i8vA:
33.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_A_ZPCA1318_2
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 7 TYR A 207
VAL A 192
ARG A 206
ASN A 196
 None
 1.05A 4a97E-4i8vA:
undetectable		 4a97E-4i8vA:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_I_ZPCI1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 7 TYR A 207
VAL A 192
ARG A 206
ASN A 196
 None
 1.13A 4a97H-4i8vA:
undetectable		 4a97H-4i8vA:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_I_ZPCI1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 7 VAL A 192
ARG A 206
ASN A 196
GLU A 213
 None
 1.08A 4a97H-4i8vA:
undetectable		 4a97H-4i8vA:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 10 VAL A 407
LEU A  86
VAL A  84
LEU A 396
VAL A  73
 None
 0.95A 4e3hA-4i8vA:
undetectable		 4e3hA-4i8vA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 10 VAL A 407
VAL A  84
LEU A 396
THR A 394
VAL A  73
 None
 1.01A 4e3hA-4i8vA:
undetectable		 4e3hA-4i8vA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K0S_A_AZMA302_1
(CARBONIC ANHYDRASE 2)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 11 VAL A 407
LEU A  96
VAL A  84
LEU A 396
THR A 394
 None
 1.29A 4k0sA-4i8vA:
undetectable		 4k0sA-4i8vA:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K38_A_SAMA504_0
(ANAEROBIC
SULFATASE-MATURATING
ENZYME
KP18CYS PEPTIDE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 TYR A 270
GLN A 290
GLN A 293
ILE A 307
CYH A 289
 None
 1.47A 4k38A-4i8vA:
undetectable
4k38D-4i8vA:
undetectable		 4k38A-4i8vA:
20.28
4k38D-4i8vA:
4.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L78_A_ACTA1327_0
(PHOSPHORIBOSYLFORMYL
GLYCINAMIDINE
SYNTHASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 4 VAL A 350
THR A 349
GLU A 346
GLU A 345
 None
 1.38A 4l78A-4i8vA:
undetectable		 4l78A-4i8vA:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4M11_C_MXMC606_2
(PROSTAGLANDIN G/H
SYNTHASE 2)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		3 / 3 LEU A 109
ARG A 106
MET A 452
 None
HEM  A 601 (-2.7A)
None
 0.87A 4m11C-4i8vA:
0.7		 4m11C-4i8vA:
22.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NKX_A_STRA601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 PHE A 123
ASN A 222
ALA A 317
THR A 321
ILE A 386
 None
BHF  A 602 ( 3.8A)
BHF  A 602 ( 3.4A)
HEM  A 601 (-3.4A)
HEM  A 601 (-3.6A)
 1.00A 4nkxA-4i8vA:
42.2		 4nkxA-4i8vA:
33.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NKX_A_STRA601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 PHE A 123
GLY A 316
ALA A 317
THR A 321
ILE A 386
 None
BHF  A 602 (-3.5A)
BHF  A 602 ( 3.4A)
HEM  A 601 (-3.4A)
HEM  A 601 (-3.6A)
 0.43A 4nkxA-4i8vA:
42.2		 4nkxA-4i8vA:
33.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NKX_C_STRC601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 PHE A 123
GLY A 316
ALA A 317
THR A 321
ILE A 386
 None
BHF  A 602 (-3.5A)
BHF  A 602 ( 3.4A)
HEM  A 601 (-3.4A)
HEM  A 601 (-3.6A)
 0.50A 4nkxC-4i8vA:
42.4		 4nkxC-4i8vA:
33.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NKX_D_STRD601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 PHE A 123
GLY A 316
ALA A 317
THR A 321
ILE A 386
 None
BHF  A 602 (-3.5A)
BHF  A 602 ( 3.4A)
HEM  A 601 (-3.4A)
HEM  A 601 (-3.6A)
 0.47A 4nkxD-4i8vA:
42.6		 4nkxD-4i8vA:
33.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PB1_A_RBVA501_1
(NUPC FAMILY PROTEIN)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 GLY A 316
ALA A 317
LEU A 496
SER A 120
ILE A 115
 BHF  A 602 (-3.5A)
BHF  A 602 ( 3.4A)
None
BHF  A 602 ( 4.5A)
BHF  A 602 (-4.7A)
 1.11A 4pb1A-4i8vA:
1.5		 4pb1A-4i8vA:
22.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PD9_A_ADNA501_1
(NUPC FAMILY PROTEIN)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 GLY A 316
ALA A 317
LEU A 496
SER A 120
ILE A 115
 BHF  A 602 (-3.5A)
BHF  A 602 ( 3.4A)
None
BHF  A 602 ( 4.5A)
BHF  A 602 (-4.7A)
 1.10A 4pd9A-4i8vA:
0.7		 4pd9A-4i8vA:
22.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RZV_B_032B801_2
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 5 ILE A 115
PHE A 384
SER A 124
ASP A 235
 BHF  A 602 (-4.7A)
None
None
None
 1.26A 4rzvB-4i8vA:
undetectable		 4rzvB-4i8vA:
20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TVT_A_ASCA305_0
(THAUMATIN-1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 5 GLU A 369
ILE A 372
PHE A 468
VAL A 467
 None
 1.35A 4tvtA-4i8vA:
undetectable		 4tvtA-4i8vA:
16.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4WNW_A_RTZA602_1
(CYTOCHROME P450 2D6)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 GLY A 453
LEU A  96
ASP A  90
VAL A 409
PHE A 103
 None
 1.13A 4wnwA-4i8vA:
42.7		 4wnwA-4i8vA:
34.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WQ5_B_ACTB404_0
(TRNA N6-ADENOSINE
THREONYLCARBAMOYLTRA
NSFERASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		3 / 3 TYR A 367
ARG A 338
LYS A 342
 None
 1.11A 4wq5B-4i8vA:
undetectable		 4wq5B-4i8vA:
23.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DNU_A_BEZA319_0
(SHKAI2IB)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 5 GLN A 290
HIS A 288
ILE A 286
TYR A 270
 None
 1.18A 5dnuA-4i8vA:
undetectable		 5dnuA-4i8vA:
21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DNU_A_BEZA319_0
(SHKAI2IB)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 5 GLN A 290
ILE A 286
ILE A 307
TYR A 270
 None
 1.25A 5dnuA-4i8vA:
undetectable		 5dnuA-4i8vA:
21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DNV_A_BEZA304_0
(SHKAI2IB)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 5 GLN A 290
HIS A 288
ILE A 286
ILE A 308
 None
 1.29A 5dnvA-4i8vA:
undetectable		 5dnvA-4i8vA:
21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DNV_A_BEZA304_0
(SHKAI2IB)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 5 GLN A 290
HIS A 288
ILE A 286
TYR A 270
 None
 1.23A 5dnvA-4i8vA:
undetectable		 5dnvA-4i8vA:
21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DNV_A_BEZA304_0
(SHKAI2IB)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 5 GLN A 290
ILE A 286
ILE A 307
TYR A 270
 None
 1.26A 5dnvA-4i8vA:
undetectable		 5dnvA-4i8vA:
21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DXE_A_ESTA1000_1
(ESTROGEN RECEPTOR)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 8 LEU A 433
LEU A 428
ARG A 338
LEU A 443
 None
 0.85A 5dxeA-4i8vA:
2.5		 5dxeA-4i8vA:
19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IAO_F_URFF301_1
(BIFUNCTIONAL PROTEIN
PYRR)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		3 / 3 ARG A 431
HIS A 378
ARG A 377
 None
 0.77A 5iaoF-4i8vA:
undetectable		 5iaoF-4i8vA:
19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IKR_A_ID8A601_2
(PROSTAGLANDIN G/H
SYNTHASE 2)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		3 / 3 VAL A 488
LEU A 174
MET A 508
 None
 0.88A 5ikrA-4i8vA:
undetectable		 5ikrA-4i8vA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L1F_A_6ZPA902_1
(GLUTAMATE RECEPTOR 2)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 8 PRO A 383
TYR A 494
PHE A 381
SER A 379
 None
None
HEM  A 601 (-4.8A)
None
 1.02A 5l1fA-4i8vA:
undetectable
5l1fB-4i8vA:
undetectable		 5l1fA-4i8vA:
20.94
5l1fB-4i8vA:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MXB_A_ML1A222_1
(CLASS 10 PLANT
PATHOGENESIS-RELATED
PROTEIN)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 10 VAL A  83
ILE A  76
LEU A  55
TYR A 494
PHE A 408
 None
 1.09A 5mxbA-4i8vA:
undetectable		 5mxbA-4i8vA:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OF1_A_SALA301_1
(SPORE
COAT-ASSOCIATED
PROTEIN N)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 5 ALA A 463
VAL A 467
PHE A 450
ILE A 372
 HEM  A 601 (-3.5A)
None
HEM  A 601 (-4.1A)
None
 0.91A 5of1A-4i8vA:
undetectable		 5of1A-4i8vA:
10.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OF1_B_SALB301_1
(SPORE
COAT-ASSOCIATED
PROTEIN N)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 5 ALA A 463
VAL A 467
PHE A 450
ILE A 372
 HEM  A 601 (-3.5A)
None
HEM  A 601 (-4.1A)
None
 0.92A 5of1B-4i8vA:
undetectable		 5of1B-4i8vA:
10.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VCE_A_RITA602_1
(CYTOCHROME P450 3A4)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 PHE A 123
SER A 116
ILE A 115
PHE A 224
ALA A 138
 None
BHF  A 602 (-3.2A)
BHF  A 602 (-4.7A)
BHF  A 602 (-3.3A)
None
 1.13A 5vceA-4i8vA:
31.3		 5vceA-4i8vA:
26.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CBZ_A_ESTA601_1
(ESTROGEN RECEPTOR)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 8 LEU A 433
LEU A 428
ARG A 338
LEU A 443
 None
 0.85A 6cbzA-4i8vA:
2.6		 6cbzA-4i8vA:
11.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_A_AQ4A602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 ASN A 222
ASN A 223
LEU A 254
PHE A 258
PHE A 319
 BHF  A 602 ( 3.8A)
None
None
BHF  A 602 ( 3.9A)
BHF  A 602 ( 4.7A)
 1.17A 6dwnA-4i8vA:
62.1		 6dwnA-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_A_AQ4A602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 ASN A 223
LEU A 254
ASN A 255
PHE A 258
PHE A 319
 None
None
None
BHF  A 602 ( 3.9A)
BHF  A 602 ( 4.7A)
 1.01A 6dwnA-4i8vA:
62.1		 6dwnA-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_A_AQ4A602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		6 / 12 SER A 120
ASN A 222
PHE A 224
ASP A 313
GLY A 316
PHE A 319
 BHF  A 602 ( 4.5A)
BHF  A 602 ( 3.8A)
BHF  A 602 (-3.3A)
BHF  A 602 (-3.7A)
BHF  A 602 (-3.5A)
BHF  A 602 ( 4.7A)
 1.49A 6dwnA-4i8vA:
62.1		 6dwnA-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_A_AQ4A602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		6 / 12 SER A 120
PHE A 224
ASP A 313
GLY A 316
PHE A 319
ASP A 320
 BHF  A 602 ( 4.5A)
BHF  A 602 (-3.3A)
BHF  A 602 (-3.7A)
BHF  A 602 (-3.5A)
BHF  A 602 ( 4.7A)
BHF  A 602 (-3.7A)
 1.48A 6dwnA-4i8vA:
62.1		 6dwnA-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_A_AQ4A602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		9 / 12 SER A 122
ASN A 222
ASN A 223
PHE A 224
PHE A 258
ASP A 313
GLY A 316
PHE A 319
ILE A 386
 HEM  A 601 (-3.4A)
BHF  A 602 ( 3.8A)
None
BHF  A 602 (-3.3A)
BHF  A 602 ( 3.9A)
BHF  A 602 (-3.7A)
BHF  A 602 (-3.5A)
BHF  A 602 ( 4.7A)
HEM  A 601 (-3.6A)
 0.69A 6dwnA-4i8vA:
62.1		 6dwnA-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_A_AQ4A602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		10 / 12 SER A 122
ASN A 223
PHE A 224
ASN A 255
PHE A 258
ASP A 313
GLY A 316
PHE A 319
ASP A 320
ILE A 386
 HEM  A 601 (-3.4A)
None
BHF  A 602 (-3.3A)
None
BHF  A 602 ( 3.9A)
BHF  A 602 (-3.7A)
BHF  A 602 (-3.5A)
BHF  A 602 ( 4.7A)
BHF  A 602 (-3.7A)
HEM  A 601 (-3.6A)
 0.48A 6dwnA-4i8vA:
62.1		 6dwnA-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_A_AQ4A602_1
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 5 ILE A 115
SER A 116
ALA A 317
LEU A 496
LYS A 499
 BHF  A 602 (-4.7A)
BHF  A 602 (-3.2A)
BHF  A 602 ( 3.4A)
None
None
 0.43A 6dwnA-4i8vA:
62.1		 6dwnA-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_B_AQ4B602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 ILE A 115
ASN A 223
PHE A 224
ASN A 255
ILE A 386
 BHF  A 602 (-4.7A)
None
BHF  A 602 (-3.3A)
None
HEM  A 601 (-3.6A)
 1.34A 6dwnB-4i8vA:
61.1		 6dwnB-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_B_AQ4B602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		8 / 12 ILE A 115
SER A 122
ASN A 222
LEU A 254
ASN A 255
PHE A 258
ASP A 313
PHE A 319
 BHF  A 602 (-4.7A)
HEM  A 601 (-3.4A)
BHF  A 602 ( 3.8A)
None
None
BHF  A 602 ( 3.9A)
BHF  A 602 (-3.7A)
BHF  A 602 ( 4.7A)
 0.90A 6dwnB-4i8vA:
61.1		 6dwnB-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_B_AQ4B602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		9 / 12 ILE A 115
SER A 122
ASN A 222
PHE A 224
ASN A 255
PHE A 258
ASP A 313
PHE A 319
ILE A 386
 BHF  A 602 (-4.7A)
HEM  A 601 (-3.4A)
BHF  A 602 ( 3.8A)
BHF  A 602 (-3.3A)
None
BHF  A 602 ( 3.9A)
BHF  A 602 (-3.7A)
BHF  A 602 ( 4.7A)
HEM  A 601 (-3.6A)
 0.75A 6dwnB-4i8vA:
61.1		 6dwnB-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_B_AQ4B602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		9 / 12 ILE A 115
SER A 122
PHE A 224
ASN A 255
ASP A 313
PHE A 319
ASP A 320
ILE A 386
LYS A 499
 BHF  A 602 (-4.7A)
HEM  A 601 (-3.4A)
BHF  A 602 (-3.3A)
None
BHF  A 602 (-3.7A)
BHF  A 602 ( 4.7A)
BHF  A 602 (-3.7A)
HEM  A 601 (-3.6A)
None
 0.44A 6dwnB-4i8vA:
61.1		 6dwnB-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_B_AQ4B602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		9 / 12 ILE A 115
SER A 122
PHE A 224
ASN A 255
PHE A 258
ASP A 313
PHE A 319
ASP A 320
ILE A 386
 BHF  A 602 (-4.7A)
HEM  A 601 (-3.4A)
BHF  A 602 (-3.3A)
None
BHF  A 602 ( 3.9A)
BHF  A 602 (-3.7A)
BHF  A 602 ( 4.7A)
BHF  A 602 (-3.7A)
HEM  A 601 (-3.6A)
 0.57A 6dwnB-4i8vA:
61.1		 6dwnB-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_B_AQ4B602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 SER A 122
LEU A 217
ASP A 313
ASP A 320
LYS A 499
 HEM  A 601 (-3.4A)
None
BHF  A 602 (-3.7A)
BHF  A 602 (-3.7A)
None
 1.35A 6dwnB-4i8vA:
61.1		 6dwnB-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_B_AQ4B602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 12 SER A 122
PHE A 315
ASP A 313
ASP A 320
LYS A 499
 HEM  A 601 (-3.4A)
None
BHF  A 602 (-3.7A)
BHF  A 602 (-3.7A)
None
 1.44A 6dwnB-4i8vA:
61.1		 6dwnB-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_B_AQ4B602_1
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		7 / 7 SER A 116
ASN A 223
PHE A 251
GLY A 316
ALA A 317
VAL A 382
LEU A 496
 BHF  A 602 (-3.2A)
None
None
BHF  A 602 (-3.5A)
BHF  A 602 ( 3.4A)
HEM  A 601 (-4.9A)
None
 0.38A 6dwnB-4i8vA:
61.1		 6dwnB-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_C_AQ4C602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		7 / 12 ASN A 222
LEU A 254
ASN A 255
PHE A 258
ASP A 313
GLY A 316
PHE A 319
 BHF  A 602 ( 3.8A)
None
None
BHF  A 602 ( 3.9A)
BHF  A 602 (-3.7A)
BHF  A 602 (-3.5A)
BHF  A 602 ( 4.7A)
 0.95A 6dwnC-4i8vA:
60.5		 6dwnC-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_C_AQ4C602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		6 / 12 ILE A 115
ASN A 223
PHE A 224
ASN A 255
ILE A 386
LEU A 496
 BHF  A 602 (-4.7A)
None
BHF  A 602 (-3.3A)
None
HEM  A 601 (-3.6A)
None
 1.44A 6dwnC-4i8vA:
60.5		 6dwnC-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_C_AQ4C602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		11 / 12 ILE A 115
SER A 122
ASN A 222
PHE A 224
ASN A 255
PHE A 258
ASP A 313
GLY A 316
PHE A 319
ILE A 386
LEU A 496
 BHF  A 602 (-4.7A)
HEM  A 601 (-3.4A)
BHF  A 602 ( 3.8A)
BHF  A 602 (-3.3A)
None
BHF  A 602 ( 3.9A)
BHF  A 602 (-3.7A)
BHF  A 602 (-3.5A)
BHF  A 602 ( 4.7A)
HEM  A 601 (-3.6A)
None
 0.63A 6dwnC-4i8vA:
60.5		 6dwnC-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_C_AQ4C602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		6 / 12 SER A 120
ASN A 222
PHE A 224
ASP A 313
GLY A 316
PHE A 319
 BHF  A 602 ( 4.5A)
BHF  A 602 ( 3.8A)
BHF  A 602 (-3.3A)
BHF  A 602 (-3.7A)
BHF  A 602 (-3.5A)
BHF  A 602 ( 4.7A)
 1.44A 6dwnC-4i8vA:
60.5		 6dwnC-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_C_AQ4C602_1
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		3 / 3 SER A 116
SER A 120
ALA A 317
 BHF  A 602 (-3.2A)
BHF  A 602 ( 4.5A)
BHF  A 602 ( 3.4A)
 0.30A 6dwnC-4i8vA:
60.5		 6dwnC-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_D_AQ4D602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		11 / 12 ILE A 115
SER A 122
ASN A 222
PHE A 224
PHE A 258
ASP A 313
GLY A 316
ALA A 317
PHE A 319
ILE A 386
LEU A 496
 BHF  A 602 (-4.7A)
HEM  A 601 (-3.4A)
BHF  A 602 ( 3.8A)
BHF  A 602 (-3.3A)
BHF  A 602 ( 3.9A)
BHF  A 602 (-3.7A)
BHF  A 602 (-3.5A)
BHF  A 602 ( 3.4A)
BHF  A 602 ( 4.7A)
HEM  A 601 (-3.6A)
None
 0.78A 6dwnD-4i8vA:
59.1		 6dwnD-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_D_AQ4D602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		11 / 12 ILE A 115
SER A 122
PHE A 224
PHE A 258
ASP A 313
GLY A 316
ALA A 317
PHE A 319
ASP A 320
ILE A 386
LEU A 496
 BHF  A 602 (-4.7A)
HEM  A 601 (-3.4A)
BHF  A 602 (-3.3A)
BHF  A 602 ( 3.9A)
BHF  A 602 (-3.7A)
BHF  A 602 (-3.5A)
BHF  A 602 ( 3.4A)
BHF  A 602 ( 4.7A)
BHF  A 602 (-3.7A)
HEM  A 601 (-3.6A)
None
 0.53A 6dwnD-4i8vA:
59.1		 6dwnD-4i8vA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DWN_D_AQ4D602_0
(CYTOCHROME P450 1A1)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		6 / 12 SER A 120
PHE A 224
ASP A 313
GLY A 316
PHE A 319
ASP A 320
 BHF  A 602 ( 4.5A)
BHF  A 602 (-3.3A)
BHF  A 602 (-3.7A)
BHF  A 602 (-3.5A)
BHF  A 602 ( 4.7A)
BHF  A 602 (-3.7A)
 1.42A 6dwnD-4i8vA:
59.1		 6dwnD-4i8vA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EF6_A_BEZA401_0
(AMINOGLYCOSIDE
PHOSPHOTRANSFERASE)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		5 / 9 LEU A  86
SER A  87
THR A  91
PRO A  40
PHE A 399
 None
 1.28A 6ef6A-4i8vA:
undetectable		 6ef6A-4i8vA:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GNG_B_QPSB601_3
(-)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		3 / 3 ASP A 101
ASP A 126
ASN A 309
 None
 0.60A 6gngB-4i8vA:
undetectable		 6gngB-4i8vA:
23.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MA6_A_MYTA603_0
(CYTOCHROME P450 3A4)		 4i8v CYTOCHROME P450 1A1
(Homo
sapiens) 		4 / 6 ARG A 106
SER A 122
ALA A 317
THR A 321
 HEM  A 601 (-2.7A)
HEM  A 601 (-3.4A)
BHF  A 602 ( 3.4A)
HEM  A 601 (-3.4A)
 1.14A 6ma6A-4i8vA:
34.2		 6ma6A-4i8vA:
8.85